These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 24138004)
21. Patent law. Law and science collide over human gene patents. Cook-Deegan R Science; 2012 Nov; 338(6108):745-7. PubMed ID: 23139317 [No Abstract] [Full Text] [Related]
22. Implications of recent US Supreme Court IP ruling for nanomedicine patents. Kim KY Nanomedicine (Lond); 2008 Apr; 3(2):141-3. PubMed ID: 18373420 [No Abstract] [Full Text] [Related]
25. Intellectual property. Supreme Court rules out patents on 'natural' genes. Marshall E Science; 2013 Jun; 340(6139):1387-8. PubMed ID: 23788772 [No Abstract] [Full Text] [Related]
26. DNA patent decision leaves questions for diagnostics. Harrison C Nat Rev Drug Discov; 2011 Aug; 10(9):650-1. PubMed ID: 21878971 [No Abstract] [Full Text] [Related]
27. Supreme Court decision on patent for HIV test unlikely to set major precedent. Waters H Nat Med; 2011 Jul; 17(7):758. PubMed ID: 21738136 [No Abstract] [Full Text] [Related]
28. The Impact of Myriad on the Future Development and Commercialization of DNA-Based Therapies and Diagnostics. Wales M; Cartier E Cold Spring Harb Perspect Med; 2015 Sep; 5(12):. PubMed ID: 26337114 [TBL] [Abstract][Full Text] [Related]
29. US Supreme Court is asked to rule on validity of patents on BRCA1 and BRCA2 genes. Dyer C BMJ; 2012 Oct; 345():e6624. PubMed ID: 23033368 [No Abstract] [Full Text] [Related]
30. Patents and laboratory medicine: what is required to turn an unpatentable natural phenomenon or law of nature into a patentable invention? Powlick JT Clin Chem; 2012 Aug; 58(8):1205-7. PubMed ID: 22504119 [No Abstract] [Full Text] [Related]
32. BRCA patent dispute may head to US Supreme Court. Devi S Lancet; 2012 Jan; 379(9813):300. PubMed ID: 22292161 [No Abstract] [Full Text] [Related]
33. Patentability of Stem Cells in the United States. Fendrick SE; Zuhn DL Cold Spring Harb Perspect Med; 2015 Aug; 5(12):. PubMed ID: 26292987 [TBL] [Abstract][Full Text] [Related]
34. Patents. U.S. Supreme Court delves into what is and isn't patentable. Marshall E Science; 2009 Jun; 324(5933):1374. PubMed ID: 19520926 [No Abstract] [Full Text] [Related]
35. Strategies for strengthening patent protection of pharmaceutical inventions in light of federal court decisions. Pillai X; Kinney WA Curr Top Med Chem; 2010; 10(18):1929-36. PubMed ID: 20615184 [TBL] [Abstract][Full Text] [Related]
36. Patenting DNA: who defines and protects the public good? Garcia SA Am J Bioeth; 2002; 2(3):25-6. PubMed ID: 12230850 [No Abstract] [Full Text] [Related]
37. Monsters at the patent office: the inconsistent conclusions of moral utility and the controversy of human cloning. Smith AR De Paul Law Rev; 2003; 53(1):159-203. PubMed ID: 15568254 [No Abstract] [Full Text] [Related]
38. Intellectual property. Supreme Court to review the scope of Monsanto's seed patents. Marshall E Science; 2013 Feb; 339(6120):639. PubMed ID: 23393238 [No Abstract] [Full Text] [Related]
39. Prometheus: the Supreme Court redefines the patentability of diagnostic inventions. Kumamoto A; Schmid CL Recent Pat DNA Gene Seq; 2012 Dec; 6(3):193-6. PubMed ID: 22812581 [TBL] [Abstract][Full Text] [Related]
40. Supreme Court will rule on whether patents for BRAC1 and BRAC2 genes are valid. Dyer C BMJ; 2012 Dec; 345():e8266. PubMed ID: 23223689 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]